Join
Live feed
·
INSIDERFilingvia Quantisnow
Scinai Immunotherapeutics Ltd. logo

Chief Executive Officer Reichman Amir was granted 400,000,000 units of Ordinary Shares, increasing direct ownership by 128% to 711,637,600 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SCNI· Scinai Immunotherapeutics Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SCNI (Scinai Immunotherapeutics Ltd.) and more on Quantisnow.